Cargando…
Combination of a Proteomics Approach and Reengineering of Meso Scale Network Models for Prediction of Mode-of-Action for Tyrosine Kinase Inhibitors
In drug discovery, the characterisation of the precise modes of action (MoA) and of unwanted off-target effects of novel molecularly targeted compounds is of highest relevance. Recent approaches for identification of MoA have employed various techniques for modeling of well defined signaling pathway...
Autores principales: | Balabanov, Stefan, Wilhelm, Thomas, Venz, Simone, Keller, Gunhild, Scharf, Christian, Pospisil, Heike, Braig, Melanie, Barett, Christine, Bokemeyer, Carsten, Walther, Reinhard, Brümmendorf, Tim H., Schuppert, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3541187/ https://www.ncbi.nlm.nih.gov/pubmed/23326482 http://dx.doi.org/10.1371/journal.pone.0053668 |
Ejemplares similares
-
Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform
por: Ummanni, Ramesh, et al.
Publicado: (2011) -
Abcg2 Overexpression Represents a Novel Mechanism for Acquired Resistance to the Multi-Kinase Inhibitor Danusertib in BCR-ABL-Positive Cells In Vitro
por: Balabanov, Stefan, et al.
Publicado: (2011) -
Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation
por: Ummanni, Ramesh, et al.
Publicado: (2011) -
Protein-protein-interaction Network Organization of the Hypusine Modification System
por: Sievert, Henning, et al.
Publicado: (2012) -
Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?
por: Hennigs, Jan K, et al.
Publicado: (2011)